La. Passani et al., DISTRIBUTION OF N-ACETYLASPARTYLGLUTAMATE IMMUNOREACTIVITY IN HUMAN BRAIN AND ITS ALTERATION IN NEURODEGENERATIVE DISEASE, Brain research, 772(1-2), 1997, pp. 9-22
The dipeptide N-acetylaspartylglutamate (NAAG) may be involved in the
process of glutamatergic signaling by both acting at glutamate recepto
rs and as a glutamate protransmitter. In the present study we determin
ed the cellular localization and distribution of NAAG-like immunoreact
ivity (NAAG-LI) in normal human brain and in neurodegenerative disorde
rs to ascertain the degree of NAAG's colocalization to putative glutam
atergic pathways. Immunohistochemistry with an antibody against NAAG w
as performed on control, Huntington's disease (HD) and Alzheimer's dis
ease (AD) human autopsy and biopsy brain sections from the cerebral co
rtex, hippocampus, amygdala, neostriatum, brainstem and spinal cord. I
n normal human brain, NAAG-LI was widespread localized to putative glu
tamatergic pyramidal neurons of the cerebral cortex and hippocampus. P
unctate NAAG-LI was present in areas known to receive neuronal glutama
tergic input, such as layer IV of the cerebral cortex, striatal neurop
il, and the outer portion of the molecular layer of the hippocampal de
ntate gyrus. In the two pathologic brain regions examined, the HD neos
triatum and the AD temporal cortex, we observed a widespread loss of N
AAG-LI neurons. In addition NAAG-LI reactive microglia surrounding pla
ques were seen in AD temporal cortex but not in the HD striatum. Our r
esults suggest that NAAG is substantially localized to putative glutam
atergic pathways in human brain and that NAAG-LI neurons are vulnerabl
e to the neurodegenerative process in HD and AD. (C) 1997 Elsevier Sci
ence B.V.